Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease

Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease

Mansour A Alghamdi,1,2 Laith AL-Eitan,3 Rami Alkhatib,3 Ahmad Al-Assi,4 Ayah Almasri,3 Hanan Aljamal,3 Hatem Aman,3 Rame Khasawneh5 1Department of Anatomy, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia; 2Genomics and Personalized Medicine Unit, College of Medicine, King Khal...

Full description

Bibliographic Details
Main Authors:	Alghamdi MA, AL-Eitan L, Alkhatib R, Al-Assi A, Almasri A, Aljamal H, Aman H, Khasawneh R
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-03-01
Series:	International Journal of General Medicine
Subjects:	warfarin pharmacogenetics single nucleotide polymorphisms inr stroke.
Online Access:	https://www.dovepress.com/variants-in-cdhr3-cacnac1-and-lta-genes-predisposing-sensitivity-and-r-peer-reviewed-article-IJGM

Similar Items

Influence of <i>SH2B3</i>, <i>MTHFD1L</i>, <i>GGCX</i>, and <i>ITGB3</i> Gene Polymorphisms on theVariability on Warfarin Dosage Requirements and Susceptibility to CVD in the Jordanian Population
by: Laith N. AL-Eitan, et al.
Published: (2020-09-01)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
by: Eljilany I, et al.
Published: (2021-08-01)

Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease
by: AL-Eitan LN, et al.
Published: (2020-11-01)

Comparisons of Methods and Outcomes of Warfarin Guideline-based Management in Patients on Warfarin Therapy whose International Normalized Ratio (INR) is Higher than Target INR at Vachiraphuket Hospital
by: Tulaya Potaros, et al.
Published: (2018-08-01)

The impact of aripiprazole on INR in a psychotic patient during warfarin therapy
by: Taha Can Tuman
Published: (2018-10-01)

Moxifloxacin-warfarin interaction
by: Yan Ji, et al.
Published: (2012-01-01)

Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings
by: Zipporah Kamuren, et al.
Published: (2018-09-01)

Incidence and risk factors of warfarin therapy complications in community hospitals, central and eastern regions, Thailand: a retrospective, multicenter, cohort study
by: Benyapha Sombat, et al.
Published: (2023-06-01)

RANDOMIZED COMPARISON OF TWO APPROACHES TO WARFARIN DOSAGE IN CARDIOVASCULAR HOSPITAL SECTION
by: L. N. Mishchenko, et al.
Published: (2015-08-01)

Warfarin Quality Metrics for Hospitalized Older Adults
by: Jessica Cohen, et al.
Published: (2018-07-01)

Efficacy and Safety of Warfarin Therapy: Comparison Between Specialized INR Clinic and General Medical Clinic
by: Osman Elsayed Osman, et al.
Published: (2022-12-01)

Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
by: Sirote Luengsupabul, et al.
Published: (2020-06-01)

Evaluation Of The Inpatients Who Apply With High INR-Level Due To Warfarine Use- A Retrospective Descriptive Study
by: İzzet Fidancı, et al.
Published: (2020-06-01)

Comparison of the effects of different treatment protocols on mortality in patients presenting with an INR≥10 due to warfarin-associated over-anticoagulation
by: Mehmet Muzaffer İslam, et al.
Published: (2023-03-01)

Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation
by: Lejla Burnazović-Ristić, et al.
Published: (2011-02-01)

Frequencies of polymorphisms in genes affecting the pharmacokinetics of warfarin in the Zaporizhzhia region
by: M. Yu. Kolesnik, et al.
Published: (2021-07-01)

Warfarin therapy and pharmacogenetics: A narrative review of regional and Iraqi studies
by: Ali Mohammed Abd Alridha, et al.
Published: (2022-01-01)

The progress of prothrombin time measurement
by: Juha Eero Horsti
Published: (2009-12-01)

Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China
by: Zhao S, et al.
Published: (2017-02-01)

The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting
by: Gediminas Urbonas, et al.
Published: (2019-01-01)

A multicenter, prospective study evaluating the impact of the clinical pharmacist-physician counselling on warfarin therapy management in Lebanon
by: Nermine S. Choumane, et al.
Published: (2018-02-01)

Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non-invasive strategy building from a cross sectional study in a low resource setting
by: Aishwarya Anand, et al.
Published: (2022-05-01)

Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report
by: Takashi Kato, et al.
Published: (2023-05-01)

Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
by: Hayato Akamatsu, et al.
Published: (2023-04-01)

Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients
by: Li Jie-Hui, et al.
Published: (2012-09-01)

Pharmacogenetics of Anticoagulation and Clinical Events in Warfarin-Treated Patients: A Register-Based Cohort Study with Biobank Data and National Health Registries in Finland
by: Vuorinen AL, et al.
Published: (2021-03-01)

Quality of anticoagulation management with warfarin among outpatients in a tertiary hospital in Addis Ababa, Ethiopia: a retrospective cross-sectional study
by: Teferi Gedif Fenta, et al.
Published: (2017-07-01)

Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
by: Assaf Gottlieb, et al.
Published: (2017-11-01)

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES
by: M. M. Loukianov, et al.
Published: (2018-03-01)

Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care
by: Salihah Aidit, et al.
Published: (2017-11-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans
by: Heidi E. Steiner, et al.
Published: (2021-10-01)

The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01)

بررسی تاثیر اسفنج ژلاتینی و شستن دهان با Tranexamic acid در جلوگیری از خونریزی پس از کشیدن دندان، در بیماران مصرف کننده وارفارین
by: علی پیمانی مجاور, et al.
Published: (2011-03-01)

Moving anticoagulation initiation and monitoring services into the community: evaluation of the Brighton and hove community pharmacy service
by: Samantha J. Ingram, et al.
Published: (2018-02-01)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
by: Abiel Roche-Lima, et al.
Published: (2020-01-01)

Anticoagulation Control of Warfarin in Pharmacist-Led Clinics Versus Physician-Led Clinics: A Prospective Observational Study
by: Alghadeeer S, et al.
Published: (2020-08-01)

Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report
by: Weam Aldiban, et al.
Published: (2022-10-01)

Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
by: AL-Eitan LN, et al.
Published: (2019-01-01)

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
by: Letícia C. Tavares, et al.
Published: (2018-05-01)